Trials / Completed
CompletedNCT01278004
Chemotherapy Induced Painful Peripheral Neuropathy Ethosuximide (The CIN-E Study)
A Randomised Double-blind Placebo-controlled Trial of the Safety and Efficacy of Ethosuximide 250mg Capsules for the Management of Chemotherapy Induced Painful Peripheral Neuropathy
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 15 (actual)
- Sponsor
- Royal Marsden NHS Foundation Trust · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is a drug trial of ethosuximide as a painkiller if you develop pain as a side effect of chemotherapy. Ethosuximide will be compared against placebo (an inactive substance) to test whether any response is a true effect of the drug, and not a 'placebo effect'.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ethosuximide | Drug will be dose escalated in order to reach maximum tolerated dose starting with 250mg. |
| DRUG | Placebo | Capsule |
Timeline
- Start date
- 2010-05-01
- Primary completion
- 2014-07-01
- Completion
- 2014-07-01
- First posted
- 2011-01-17
- Last updated
- 2016-05-26
Locations
2 sites across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT01278004. Inclusion in this directory is not an endorsement.